Trump announces trade deal with EU following months of negotiations
Mora Elizabeth, a director at MKS Instruments Inc. (NASDAQ:MKSI), recently sold 275 shares of the company’s common stock. The transaction took place on March 3, 2025, at a price of $92.46 per share, amounting to a total sale value of $25,426. The sale comes as the $5.8 billion semiconductor equipment maker’s stock trades near its 52-week low of $84.97, having declined over 10% in the past week. According to InvestingPro data, analysts maintain price targets ranging from $110 to $160, suggesting potential upside. Following this sale, Elizabeth holds 17,384.055 shares directly. This transaction was executed under a Rule 10b5-1 trading plan, which was set up by Elizabeth on February 15, 2024. InvestingPro analysis indicates the stock is trading at an attractive PEG ratio of 0.28, suggesting undervaluation relative to its growth prospects. For deeper insights into MKSI’s valuation and 11 additional ProTips, explore the comprehensive Pro Research Report available on InvestingPro.
In other recent news, MKS Instruments reported strong financial performance in the fourth quarter, with revenue and earnings per share exceeding both guidance and market consensus. Despite this, the company’s guidance for the upcoming quarter indicates a 3% decrease in revenue, aligning with consensus expectations. Analysts at Benchmark and Needham have adjusted their price targets for MKS Instruments to $135 and $145, respectively, while maintaining a Buy rating. Similarly, JPMorgan revised its price target to $135, maintaining an Overweight rating, citing the company’s impressive December quarter performance.
KeyBanc also reaffirmed an Overweight rating with a $160 price target, highlighting MKS Instruments’ advantageous market position. Goldman Sachs, however, slightly increased its price target to $129 and maintained a Neutral rating, noting a weaker forecast for the Specialty Industrial segment. MKS Instruments has made progress in reducing its debt, with management taking steps to alleviate financial burdens through term loan adjustments. The company anticipates growth in its Semiconductor segment, driven by increased DRAM sales and a recovery in NAND capital expenditures. Investors are keeping an eye on the company’s strategic moves and market trends, as these developments shape MKS Instruments’ outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.